| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |